All coverage
Industry fights over global vaccine patents are just warming up
By Christopher Rowland
Angela Merkel rejects US move to waive patents on vaccines
By Guy Chazan, Hannah Kuchler & Jim Brunsden
Explainer: COVID-19 vaccine patents dominate global trade talks
By Philip Blenkinsop
Biden Backs Waiving International Patent Protections For COVID-19 Vaccines
By Emma Bowman & Ashish Valentine
Explained: Intellectual property waiver for Covid-19 vaccines
By Aanchal Magazine & Prabha Raghavan
Waiver of patent rights on Covid-19 vaccines, in near term, may be more symbolic than substantive
By Helen Branswell, Matthew Herper & Damian Garde
Covid: The vaccine patent row explained
By Dharshini David
Germany rejects U.S. proposal to waive patents on COVID-19 vaccines
By Madeline Chambers, Douglas Busvine & Andreas Rinke
U.S. reverses stance, backs giving poorer countries access to COVID vaccine patents
By Jeff Mason, Andrea Shalal-Esa & David Lawder
U.S. backs waiving patent protections for Covid vaccines, citing global health crisis
By Thomas Franck, Kevin Breuninger & Amanda Macias
Biden administration to waive vaccine patent protection - The Washington Post
By Dan Diamond, Tyler Pager & Jeff Stein
TRIPS waiver: there's more to the story than vaccine patents
By Hyo Yoon Kang, Siva Thambisetty & Jocelyn Bosse